Understanding Pyruvate Dehydrogenase Complex Deficiency (PDCD)
This study aims to better understand Pyruvate Dehydrogenase Complex Deficiency (PDCD), a condition that affects how your body uses carbohydrates for energy, especially in the brain. Researchers will collect information about your medical history, how current treatments like dietary supplements, medications, and the ketogenic diet have worked for you, and review your medical records. For some participants, advanced genetic testing will be performed to explore the genetic causes of PDCD. The goal is to improve our understanding of the disease, its symptoms, and how different treatments affect outcomes. You may be eligible if you have low Pyruvate Dehydrogenase Complex (PDC) activity in your cells or a known genetic change linked to PDCD. The study is currently ongoing, but its exact recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information without providing any new treatments. It plans to include about 150 participants with PDCD.
- What's involved
- You would complete a questionnaire about your medical history and experiences with PDCD. Researchers will also review your medical records, and in some cases, perform advanced genetic testing.
- Compensation
- Not stated in the trial record.
- Follow-up
- Survival outcomes will be measured from birth until the last known date you were living at the time of data analysis.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies
At a glance
Conditions
NCT03056794
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Pittsburgh
Pittsburgh, Pennsylvaniano site contact published
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jirair K. Bedoyan, MD, PhD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Survival outcomes in pyruvate dehydrogenase deficiency diseaseData will be collected about duration of survival from birth until the last date known to be living at the time of data analysis.
Survival will be measured in years and months.